EPN Epsilon Healthcare Limited
Healthcare · Drug Manufacturers - Specialty & Generic
· website
$0.03
52wk 0.02 – 0.04
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About Epsilon Healthcare Limited
Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulation; and provision of pharmacy services and patient care. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Southport, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$10.12M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
0.77
EV / EBITDA
-9.09
Price / Book
5.20
ROE
—
Operating margin
-0.3%
Net margin
-13.6%
Total cash
$242,862
Total debt
$10.35M
Current ratio
1.17
Debt / Equity
5.41
Free cash flow
$2.41M
Avg volume
149,725
Latest annual results
(FY ending 31 Dec 2025)
- Revenue$9.39M
- Gross profit$5.76M
- Operating income-$2.38M
- Net income-$1.28M
- Diluted EPS-0.00
- Free cash flow-$3.30M
- Net debt$10.11M